Struggling With Great Stock Picks? Discover StockInvest.us Top Gems!

Range Low Price High Price Comment
30 days $1.71 $1.96 Friday, 10th May 2024 SYBX stock ended at $1.79. This is 2.19% less than the trading day before Thursday, 9th May 2024. During the day the stock fluctuated 2.23% from a day low at $1.79 to a day high of $1.83.
90 days $1.55 $2.16
52 weeks $0.234 $5.71

Historical Synlogic Inc prices

Date Open High Low Close Volume
Oct 05, 2023 $2.99 $2.99 $2.87 $2.91 12 229
Oct 04, 2023 $2.63 $3.07 $2.63 $2.91 33 755
Oct 03, 2023 $2.93 $2.93 $2.60 $2.63 113 579
Oct 02, 2023 $2.90 $2.93 $2.68 $2.85 46 414
Sep 29, 2023 $2.58 $3.00 $2.55 $2.81 144 105
Sep 28, 2023 $3.60 $5.71 $2.96 $3.16 310 039
Sep 27, 2023 $0.330 $0.381 $0.234 $0.279 1 688 794
Sep 26, 2023 $0.300 $0.345 $0.300 $0.330 246 303
Sep 25, 2023 $0.360 $0.360 $0.297 $0.299 208 599
Sep 22, 2023 $0.339 $0.354 $0.311 $0.334 79 895
Sep 21, 2023 $0.334 $0.356 $0.330 $0.345 77 272
Sep 20, 2023 $0.335 $0.378 $0.320 $0.342 89 252
Sep 19, 2023 $0.396 $0.396 $0.287 $0.319 200 602
Sep 18, 2023 $0.370 $0.415 $0.353 $0.408 347 749
Sep 15, 2023 $0.340 $0.369 $0.305 $0.369 217 857
Sep 14, 2023 $0.239 $0.350 $0.239 $0.336 608 063
Sep 13, 2023 $0.310 $0.340 $0.246 $0.247 572 901
Sep 12, 2023 $0.370 $0.376 $0.340 $0.340 313 201
Sep 11, 2023 $0.435 $0.442 $0.363 $0.364 720 248
Sep 08, 2023 $0.483 $0.490 $0.452 $0.460 48 513
Sep 07, 2023 $0.461 $0.498 $0.454 $0.465 32 362
Sep 06, 2023 $0.477 $0.486 $0.438 $0.450 97 121
Sep 05, 2023 $0.477 $0.498 $0.477 $0.477 23 971
Sep 01, 2023 $0.490 $0.500 $0.470 $0.471 41 768
Aug 31, 2023 $0.505 $0.510 $0.490 $0.490 19 178
Click to get the best stock tips daily for free!

About Synlogic Inc

Synlogic Synlogic, Inc., a clinical-stage biopharmaceutical company, engages in the discovery and development of synthetic biotic medicines to treat metabolic and immunological diseases in the United States. Its therapeutic programs include SYNB1618 and SYNB1934 that are orally administered, non-systemically absorbed drug candidates, which are in Phase II clinical trials to treat phenylketonuria; SYNB1353, an orally administered, non-systemically absorbed... SYBX Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT